While AliveCore faced two wins, the dispute did not end there. In March 2025, Apple triumphed in a major patent dispute with ...

AliveCor announced today that it received FDA clearance for the next generation of its AI technology for the Kardia 12L ECG ...

Apple Inc.‘s win in a high profile antitrust battle with medical device company AliveCor Inc. over the Apple Watch’s heart ...

The newly cleared features include three rhythm modifiers and two axis-related morphology determinations: RAD and LAD.

Smartphone-enabled ECG medical device maker AliveCor and Greatcall, which makes a line of mobile phones and health services marketed to seniors, have partnered to bring the AliveCor device to ...

AliveCor, the global leader in AI-powered cardiology, today announced it has received U.S. Food and Drug Administration (FDA) clearance for the next generation of KAI 12L--the AI powering the Kardia ...

On March 7, 2025, the Federal Circuit issued a decision resolving the ongoing patent litigation between AliveCor and Apple concerning methods of cardiac monitoring purportedly employed in certain of ...

If there's one device that's recently become a symbol for the promise -- and potential pitfalls -- of mobile health, it's AliveCor Heart Monitor, formerly known as the AliveCor iPhone ECG, which ...

AliveCor has spent years battling with Apple over the market for consumer heart monitoring technology. Now it’s hoping to make its imprint on professional health care with its new device, which ...

AliveCor, Inc. v. Apple, Inc., No. 23-1512 (Fed. Cir. 2025) – On March 7, 2025, the Federal Circuit affirmed the Patent Trial and Appeal Board’s inter partes review (“IPR”) decisions invalidating all ...

Feb 7, 2025, 6:18am CST Updated: Feb 10, 2025, 7:42am CST Photo provided by Priya Abani Priya Abani, CEO & President, AliveCor, Palo Alto, California Healthcare is complicated, to say the least. Priya ...